Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo Controlled Trial of Nitrous Oxide/Oxygen Plus Standard Care Versus Standard Care Alone During In-office Intradetrusor onabotulinumtoxinA (Botox) Injections

NCT07387315 is registered in ClinicalTrials.gov with TriHealth Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07387315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo Controlled Trial of Nitrous Oxide/Oxygen Plus Standard Care Versus Standard Care Alone During In-office Intradetrusor onabotulinumtoxinA (Botox) Injections
Lead sponsor
TriHealth Inc.
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
December 31, 2026
Enrollment
96 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neurogenic bladder, overactive bladder, pain, pelvic floor disorders, urge incontinence, urinary bladder neurogenesis, urinary bladder, neurogenic, urinary bladder, overactive, urinary incontinence, urinary incontinence, urge